{
    "title": "AstraZeneca sells former blockbuster cholesterol drug for $320 mln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9004435/AstraZeneca-sells-cholesterol-drug-rights-Gr-nenthal-320-mln.html",
    "date": "2020-12-01",
    "keywords": [
        "astrazeneca",
        "crestor",
        "cancer",
        "blockbuster",
        "drug",
        "company",
        "gruenenthal",
        "gmbh",
        "drugmaker",
        "revenue",
        "race",
        "atacand",
        "aakash",
        "b",
        "dec",
        "tuesday",
        "cholesterol",
        "payment",
        "portfolio",
        "bestselling",
        "companys",
        "arrival",
        "tagrisso",
        "imfinzi",
        "fasenra",
        "asthma",
        "vaccine",
        "novel",
        "coronavirus",
        "business",
        "start",
        "lung",
        "treatment",
        "turnaround",
        "europe",
        "transition",
        "period",
        "america",
        "china",
        "deal",
        "quarter",
        "gr\u00fcnenthal",
        "heart",
        "failure",
        "blood",
        "pressure",
        "arzneimittel",
        "divestment",
        "guidance",
        "reporting",
        "jagadeesh",
        "babu",
        "bengaluru",
        "editing",
        "chakrabarty",
        "louise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}